Latest News

4SC and Maruho end collaboration on Kv1.3 blockers

© 4SC AG


Japanese dermatology specialist Maruho Co. Ltd and drug discovery firm 4SC AG have terminated their development agreement related to 4SC's blockers of Kv1.3 ion channels, which are required for maintenance of activation of T cells. 4SC reacquired all rights to the preclinical development programme, which was aimed at specifically calm down chronically stimulated memory T-cell populations with Kv1.3highIK-1low phenotype as a strategy to treat autoimmune diseases.

The companies gave no reasons for the end of their collaboration. 4SC’s CEO Jason Loveridge, however, said that "a good deal of progress has been made" in the three years of the collaboration. Under the terminated colloaboration, 4SC had granted Maruho the exclusive worldwide rights to develop and commercialise two classes of these blockers in exchange for US-$103 in milestones plus royalties.

Novo Holdings co-leads €40m Qure.ai financing

Qure.ai said it will use the proceeds from the $40m financing round to intesify product development for  critical care and community...

G7 heads call for decarbonisation of industry

The G7 ministers underlined the importance of efforts to improve energy efficiency, the need for increased investment in renewable energy, tracking...

Study shows advantages of cellular agriculture

Replacing animal-source foods (ASFs) with novel or future foods (NFFs) – such as cultured milk, insect meal or mycoprotein – or plant-based...

International Vaccine Institute – IVI – will locate its European office in Stockholm

The International Vaccine Institute, IVI, is establishing itself outside South Korea for the first time. Last week, the Swedish Parliament ratified...

Evotec and BMS intensify R&D on protein degraders

Abliva decides on a SEK200m financing to fund Phase 2/3 study

Swedish Abliva is focussing on mitochondrial medicine, developing therapeutics for primary mitochondrial diseases, orphan indications of high unmet...

Avantium closes financing for FDCA plant

Polyethylene furanoate (PEF) is 100% fossil-free when  made from 2,5-furandicarboxylic acid (FDCA) with fructose as a carbon source und...